{"gene":"PPP1R8","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1995,"finding":"NIPP-1 was cloned from bovine thymus as a 351-residue nuclear protein (38.5 kDa calculated mass) that potently inhibits PP1 catalytic subunit; its central third (residues 143-217) is sufficient for PP1 inhibition (IC50 ~0.3 nM), and phosphorylation by PKA or CK2 reduces its inhibitory potency. The C-terminus of NIPP-1 is nearly identical to the human ard-1 protein, and their mRNAs are generated by alternative splicing of the same pre-mRNA. Western blot showed a single nuclear polypeptide of 47 kDa.","method":"cDNA cloning, bacterially expressed recombinant protein PP1 inhibition assay, phosphorylation assay, Western blot, Northern analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of PP1 inhibition with recombinant domain fragments, mutagenesis/phosphorylation functional assays, replicated in subsequent papers","pmids":["7499293"],"is_preprint":false},{"year":1993,"finding":"NIPP-1a and NIPP-1b (16-18 kDa isoforms) are excellent substrates for PKA (Km = 0.1 µM); maximal PKA phosphorylation (1.5 mol phosphate/mol NIPP-1) caused an 8-fold increase in IC50 for PP1 inhibition and decreased binding of NIPP-1 to immobilized PP1. Dephosphorylation by PP2A (but not PP1) reactivated NIPP-1. The nuclear PP1 holoenzyme PP-1Nα containing NIPP-1 was activated 6-fold by PKA, opposite to the known inhibition of cytoplasmic PP1 by PKA.","method":"In vitro kinase assay, PP1 inhibition assay, immobilized PP1 binding assay, phosphatase reactivation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase/phosphatase reconstitution with quantitative IC50 measurements, multiple orthogonal methods","pmids":["8390458"],"is_preprint":false},{"year":1997,"finding":"Baculovirus-expressed NIPP-1 is a potent PP1 inhibitor (Ki = 9.9 pM). PKA phosphorylates Ser178 and Ser199; CK2 phosphorylates Thr161 and Ser204. At physiological ionic strength, phosphorylation by PKA or CK2 drastically reduced inhibitory potency of free NIPP-1. Phosphorylation of NIPP-1 within the PP1:NIPP-1 holoenzyme activated the holoenzyme without releasing NIPP-1.","method":"Baculovirus expression, in vitro kinase assay, tryptic phosphopeptide sequencing, phosphoamino acid analysis, PP1 inhibition assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — recombinant protein, site-specific phosphorylation mapped by peptide sequencing, quantitative enzymatic assays","pmids":["9407077"],"is_preprint":false},{"year":1997,"finding":"NIPP-1 displays RNA-binding properties, preferentially binding U-rich sequences including AUUUA motifs; it also binds single-stranded DNA but not double-stranded DNA. The C-terminus of NIPP-1 mediates RNA binding. RNA binding was not affected by PKA or CK2 phosphorylation. PP1 catalytic subunit alone does not bind poly(U)-Sepharose but binds tightly after complexation with NIPP-1, suggesting NIPP-1 targets PP1 to RNA.","method":"North-Western analysis, UV cross-linking, RNA mobility-shift assay, poly(U)-Sepharose chromatography","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal RNA-binding assays with recombinant protein, antibody competition, replicated in subsequent mapping studies","pmids":["9268347"],"is_preprint":false},{"year":1999,"finding":"The PP1-binding and inhibitory function of NIPP-1 maps to the central domain (residues 143-217), with the inhibitory core narrowed to residues 191-200. A second non-inhibitory PP1-binding site contains the RVXF motif (residues 200-203); V201A and F203A substitutions or phosphorylation of Ser199 or Ser204 abolished PP1C binding at this site. The central domain peptide competed for PP1 inhibition by full-length NIPP-1 and inhibitor-1/inhibitor-2.","method":"Yeast two-hybrid, co-sedimentation, far-Western (digoxigenin-conjugated PP1C), synthetic peptide competition assay, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (yeast 2-hybrid, far-Western, peptide competition, mutagenesis) in a single rigorous study","pmids":["10318819"],"is_preprint":false},{"year":1999,"finding":"NIPP1 exhibits a speckled nucleoplasmic distribution co-localizing with pre-mRNA splicing factors (including Sm proteins) in nuclear speckles. Sm splicing factor co-immunoprecipitates with NIPP1 from nuclear extracts. Immunodepletion of NIPP1 from nuclear extracts, or addition of a dominant-negative mutant lacking a functional PP1-binding site, greatly reduces pre-mRNA splicing activity in vitro, implicating the NIPP1-PP1 complex in splicing control.","method":"Immunofluorescence, co-immunoprecipitation, immunodepletion, in vitro splicing assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, immunodepletion with functional readout (splicing assay), co-localization; replicated in subsequent studies","pmids":["9858469"],"is_preprint":false},{"year":1999,"finding":"The C-terminal region of NIPP1 (residues 311-351) contains an additional PP1 inhibitory binding site with inhibitory core at residues 331-337. This site is regulated by tyrosine phosphorylation of Tyr335 (by Lyn kinase, but only in the presence of RNA) and by RNA addition, both of which decrease inhibitory potency. The RNA-binding domain maps to C-terminal residues 330-351. Full-length NIPP1 requires both the central and C-terminal PP1-binding domains cooperatively for inhibition of myelin basic protein dephosphorylation.","method":"Site-directed mutagenesis, in vitro PP1 inhibition assay, in vitro kinase assay with Lyn","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and kinase assay, multiple sites mapped, single lab","pmids":["11104670"],"is_preprint":false},{"year":1999,"finding":"The RNA-binding domain of NIPP1 maps to C-terminal residues 330-351; a synthetic peptide of this sequence equals intact NIPP1 in RNA-binding affinity. An alternatively spliced fragment NIPP1(225-351)/Ard1 displays single-strand Mg2+-dependent endoribonuclease activity. Full-length NIPP1 and NIPP1(143-351) lack endoribonuclease activity, indicating the central domain restrains this activity. The endoribonuclease catalytic site also resides in the C-terminal 22 residues.","method":"Recombinant fragment analysis, RNA-binding assay, endoribonuclease activity assay with recombinant fragments","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution with mapped deletion fragments, multiple domain constructs tested","pmids":["10432294"],"is_preprint":false},{"year":2000,"finding":"The N-terminal FHA (Forkhead-Associated) domain of NIPP1 interacts with CDC5L (a regulator of G2/M progression and pre-mRNA splicing) in a phosphorylation-dependent manner; cyclin E-Cdk2 phosphorylation of CDC5L enables this interaction. CDC5L, NIPP1, and PP1 form a complex in rat liver nuclear extracts demonstrated by co-immunoprecipitation and co-purification. CDC5L and NIPP1 co-localize in nuclear speckles. The FHA domain blocks beta-globin pre-mRNA splicing in nuclear extracts, and an FHA mutation abolishing CDC5L interaction also cancels the anti-splicing effect.","method":"Yeast two-hybrid, co-immunoprecipitation, co-purification, immunofluorescence co-localization, in vitro splicing assay, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP/co-purification, FHA domain mutagenesis linked to functional splicing defect, co-localization","pmids":["10827081"],"is_preprint":false},{"year":2000,"finding":"Nuclear and subnuclear targeting of NIPP1 are mediated by distinct sequences: active nuclear import requires two independent NLS signals in the central domain (which partially overlap with PP1-binding sites), while concentration in nuclear speckles requires the FHA domain in the N-terminus. The FHA domain is also required for nuclear retention when active transport is blocked.","method":"EGFP fusion protein expression in HeLa/COS-1 cells, deletion mutagenesis, live-cell fluorescence microscopy","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — systematic deletion mutant analysis in two cell lines, direct localization with functional domain mapping","pmids":["11034904"],"is_preprint":false},{"year":2002,"finding":"NIPP1 is a component of spliceosomes in HeLa cell splicing extracts, requiring a functional FHA domain for spliceosomal interaction. Dominant-negative NIPP1 mutants lacking residues 225-329 block splicing at the transition between the B-complex and C-complex (a late phase of spliceosome assembly). This spliceosomal function is independent of PP1-binding and RNA-binding capacity.","method":"In vitro splicing assay, spliceosome complex analysis, site-directed mutagenesis, HeLa nuclear extracts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro spliceosome assembly assay with defined mutants, domain dissection, functional readout","pmids":["11909864"],"is_preprint":false},{"year":2002,"finding":"The FHA domain of NIPP1 interacts in vitro and in vivo with the splicing factor SAP155/SF3b(155) in a phosphorylation-dependent manner, specifically requiring phosphorylation of TP dipeptide motifs in SAP155 by Ca2+-dependent, roscovitine-sensitive (CDK) kinases. Various phosphorylated TP motifs compete for the same FHA binding site. SAP155 phosphorylation is dramatically increased during mitosis.","method":"Co-immunoprecipitation, in vitro binding assay, mutagenesis, kinase inhibitor treatment, mitotic cell analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro and in vivo co-IP, competition assays, mutagenesis, cell-cycle context established","pmids":["12105215"],"is_preprint":false},{"year":2003,"finding":"The FHA domain of NIPP1 interacts with the cell cycle-regulated kinase MELK (maternal embryonic leucine zipper kinase), dependent on phosphorylation of Thr-478 of MELK and increased in mitotically arrested cells. Recombinant MELK (including kinase-dead mutant) inhibits an early step of spliceosome assembly in nuclear extracts, but a T478A MELK mutant that cannot bind NIPP1 lacks this splicing inhibition, indicating NIPP1 mediates MELK's inhibitory effect on splicing.","method":"Co-immunoprecipitation, in vitro spliceosome assembly assay, recombinant MELK protein, kinase-dead and phosphosite mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional spliceosome assay with phosphosite mutant epistasis, co-IP, recombinant proteins","pmids":["14699119"],"is_preprint":false},{"year":2003,"finding":"NIPP1 interacts with the Polycomb group protein EED (embryonic ectoderm development) via two interaction domains in the central and C-terminal thirds of NIPP1, identified by yeast two-hybrid and confirmed in vivo. (d)G-rich nucleic acids potentiate the NIPP1-EED interaction and also decrease NIPP1's potency as a PP1 inhibitor, but do not prevent formation of a ternary NIPP1·EED·PP1 complex. NIPP1 acts as a transcriptional repressor of targeted genes through its EED interaction domain; histone deacetylase 2 (HDAC2) is also present in a complex with NIPP1.","method":"Yeast two-hybrid, co-immunoprecipitation, transcription reporter assay, domain mutagenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — yeast 2-hybrid plus co-IP, transcription repression assay, single lab","pmids":["12788942"],"is_preprint":false},{"year":2004,"finding":"NIPP1 knockout mice (NIPP1-/-) show severely retarded growth at E6.5 and are resorbed by E8.5; lethality is not associated with increased apoptosis but correlates with impaired cell proliferation. Blastocyst outgrowth and siRNA knockdown in cultured cells confirm an essential role for NIPP1 in cell proliferation. No viable NIPP1-/- cell lines could be established.","method":"Homologous recombination knockout, blastocyst outgrowth, RNA interference knockdown, cell proliferation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout in mice with multiple confirmatory approaches (blastocyst outgrowth, RNAi), clear proliferation phenotype","pmids":["15199142"],"is_preprint":false},{"year":2007,"finding":"NIPP1 is required for EZH2-mediated trimethylation of histone H3 on Lys27 (H3K27me3) both during embryonic development and in proliferating cells. Knockdown of NIPP1 reduces H3K27me3 globally; NIPP1 and EZH2 silence a common set of genes; NIPP1 is associated with Polycomb target genes and H3K27me3-enriched regions. Knockdown of either NIPP1 or EZH2 causes loss of H3K27me3 at target loci.","method":"RNAi knockdown, ChIP, gene-expression profiling, NIPP1-deficient cells","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, gene-expression profiling, and genetic depletion with multiple orthogonal readouts","pmids":["17724462"],"is_preprint":false},{"year":2007,"finding":"Transcriptional repression by NIPP1 is mediated by PRC2 components EED and EZH2: RNAi knockdown of EED or EZH2, or overexpression of catalytically dead EZH2, alleviates NIPP1-mediated repression. NIPP1 is present in a complex with EED and EZH2 in vivo and has distinct binding sites for these proteins.","method":"RNAi knockdown, co-immunoprecipitation, transcription reporter assay, catalytic-dead EZH2 mutant","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — co-IP plus functional reporter assay plus genetic depletion, single lab","pmids":["17804093"],"is_preprint":false},{"year":2008,"finding":"NIPP1 recruits PP1 to SAP155 (Sap155) via its FHA domain, which recognizes hyperphosphorylated Sap155, and promotes Sap155 dephosphorylation. NIPP1 acts as a molecular sensor: it stimulates Sap155 dephosphorylation by PP1 in vitro by facilitating their interaction, then dissociates from Sap155 after dephosphorylation. A C-terminally truncated NIPP1 (NIPP1-ΔC) forms a hyperactive holoenzyme with PP1 that dramatically reduces Sap155 hyperphosphorylation and inhibits splicing.","method":"Co-immunoprecipitation, in vitro dephosphorylation assay, siRNA knockdown, overexpression of truncation mutants, splicing assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro reconstitution of dephosphorylation, multiple mutant constructs, functional splicing readout, siRNA confirmation","pmids":["18842582"],"is_preprint":false},{"year":2010,"finding":"NIPP1 forms a complex with PP1 and PRC2 components (including EZH2) on chromatin. Knockdown of NIPP1 or PP1 reduces EZH2 association with a subset of its target genes; overexpression of NIPP1 retargets EZH2 from fully repressed to partially active PcG targets. A PP1-binding mutant of NIPP1 (NIPP1m) does not cause EZH2 redistribution and shows deficient chromatin binding at Polycomb target loci (DamID mapping). NIPP1 associates with multiple PcG target genes including the Homeobox A cluster.","method":"Co-immunoprecipitation, ChIP, DamID chromatin mapping, siRNA knockdown, overexpression","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, DamID genome-wide, co-IP, PP1-binding mutant epistasis, multiple orthogonal methods","pmids":["20671031"],"is_preprint":false},{"year":2012,"finding":"Crystal/NMR structure of the PP1-binding domain of NIPP1 shows it is intrinsically disordered and binds PP1 by forming an α-helix that engages PP1 at a unique interaction site using polar (not hydrophobic) contacts. The structure reveals a shared PP1 interaction site outside the RVxF motif, the ΦΦ motif. NIPP1:PP1 substrate selectivity is determined by altered electrostatics and enhanced substrate localization.","method":"Structural determination (NMR/crystallography with functional validation), mutagenesis, substrate specificity assay","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — structure determination with functional validation of interaction mechanism and substrate selectivity","pmids":["22940584"],"is_preprint":false},{"year":2012,"finding":"CDK-mediated phosphorylation of EZH2 at Thr416 creates a docking site for the FHA domain of NIPP1. Recruited NIPP1 inhibits PP1-mediated dephosphorylation of EZH2, thereby enabling net EZH2 phosphorylation. A NIPP1-binding mutant of EZH2 is hypophosphorylated; NIPP1 knockdown reduces endogenous EZH2 phosphorylation; PP1 loss is associated with EZH2 hyperphosphorylation. Genome-wide promoter profiling shows NIPP1-binding mutant EZH2 has deficient association with ~one-third of Polycomb target genes (proliferation-related). PP1 is identified as an EZH2 phosphatase.","method":"Co-immunoprecipitation, phospho-specific antibody, siRNA knockdown, genome-wide ChIP-seq/promoter binding profiling, site-directed mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-IP, phospho-antibody, genome-wide profiling, mutagenesis), mechanistic chain established","pmids":["23241245"],"is_preprint":false},{"year":2012,"finding":"PP1/NIPP1 regulates directional cell migration: genetic disruption of PP1 or NIPP1 decreases directional migration; inducible NIPP1 expression switches HeLa directional response from cathodal to anodal in a PP1-dependent manner. PP1:NIPP1 upregulates Cdc42 GTPase signaling; pharmacological Cdc42 inhibition in NIPP1-overexpressing cells recovers cathodal migration.","method":"Electrotaxis assay, siRNA knockdown, inducible overexpression, Cdc42 activity assay, pharmacological inhibition","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — functional migration assay with genetic and pharmacological perturbations, PP1-dependency established, Cdc42 pathway placement","pmids":["22815811"],"is_preprint":false},{"year":2006,"finding":"In hypoxia, PP1γ activity is inhibited at least in part through increased association with NIPP1, an event dependent on decreased basal cAMP/PKA signaling. A dominant-negative NIPP1 construct rescues CREB activity and CREB-dependent transcription in hypoxia, demonstrating NIPP1 mediates decreased PP1γ activity and altered metabolic gene expression under hypoxic conditions.","method":"Co-immunoprecipitation, dominant-negative NIPP1 expression, reporter assay, ATP measurement","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — co-IP and dominant-negative functional assay, single lab, PKA-dependency established","pmids":["16826568"],"is_preprint":false},{"year":2015,"finding":"Mild stable overexpression of NIPP1 in HeLa cells causes a massive induction of mesenchymal genes (smooth/cardiac-muscle and matrix markers), formation of actin-based stress fibers and retracting filopodia, and reduced proliferation. This mesenchymal transition requires functional substrate-binding (FHA) and PP1-binding domains of NIPP1, indicating it involves selective dephosphorylation of PP1:NIPP1 substrates.","method":"Stable inducible overexpression, gene expression analysis, immunofluorescence (actin cytoskeleton), domain mutagenesis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — domain mutant dissection with transcriptomic and cytoskeletal readouts, single lab","pmids":["25907536"],"is_preprint":false},{"year":2017,"finding":"Inducible, testis-specific NIPP1 knockout in adult mice results in gradual loss of germ cells (Sertoli-cell only phenotype), decreased proliferation and survival of spermatogenic lineage cells including undifferentiated spermatogonia. NIPP1 removal from cultured testis slices and isolated germ cells also reduces proliferation, indicating a testis-intrinsic requirement.","method":"Tamoxifen-inducible Cre knockout, histology, proliferation assay, ex vivo testis culture, RNA sequencing","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with tissue-specific deletion, multiple cellular and ex vivo readouts","pmids":["29042623"],"is_preprint":false},{"year":2018,"finding":"PP1:NIPP1 fusions (covalently linked holoenzyme) cause replication stress requiring both PP1 catalytic activity and FHA domain-mediated substrate recruitment. PP1-NIPP1 expression leads to accumulation of RNA-DNA hybrids (R-loops), enhanced chromatin compaction, diminished DNA double-strand break repair, and reduced expression of DNA damage signaling/repair proteins.","method":"Inducible stable cell lines with PP1-NIPP1 fusion proteins, R-loop detection, DSB assay, chromatin compaction assay, gene expression analysis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — engineered covalent holoenzyme fusion with domain-mutant controls, multiple orthogonal readouts","pmids":["29898919"],"is_preprint":false},{"year":2018,"finding":"Testis-specific NIPP1 deletion causes hyperphosphorylation of EZH2 at CDK sites Thr345 and Thr487 (due to loss of PP1-mediated dephosphorylation), leading to proteolytic EZH2 degradation and reduction in H3K27me3. Alanine mutations at these CDK sites prolong EZH2 half-life in germ cells. PP1:NIPP1 holoenzyme stabilizes EZH2 through dephosphorylation.","method":"Conditional knockout, phospho-specific antibody, alanine mutagenesis of EZH2, protein half-life assay, ChIP for H3K27me3","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — phosphosite mutagenesis with functional rescue, in vivo knockout, H3K27me3 ChIP, mechanistic chain established","pmids":["30305391"],"is_preprint":false},{"year":2021,"finding":"NIPP1 inhibits PP1γ-mediated dephosphorylation of histone H3-Thr11 (H3-pThr11) both in vivo and in vitro. Upon DNA damage, activated PKA phosphorylates NIPP1-Ser199 (adjacent to the PP1-binding RVxF motif), triggering dissociation of NIPP1 from PP1γ, thereby activating PP1γ and enabling H3-pThr11 dephosphorylation and transcriptional repression of E2F1 target genes. NIPP1 depletion reduces expression of E2F1 target genes.","method":"In vitro PP1 inhibition assay, co-immunoprecipitation, NIPP1 depletion, PKA inhibitor treatment, ChIP for H3-pThr11","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro dephosphorylation assay, in vivo co-IP with phosphosite, functional gene expression readout, single lab","pmids":["33939241"],"is_preprint":false},{"year":2023,"finding":"In C. elegans, loss of sut-6/NIPP1 or a C-terminal truncation (W292X, removing the RNA-binding domain) suppresses tau toxicity, tau protein accumulation and neuronal loss. Epistasis studies show that sut-6 suppression of tauopathy is independent of other nuclear speckle-localized suppressors (sut-2, aly-1/aly-3, spop-1). Neuronal overexpression of the W292X mutant (but not wild-type SUT-6) reduces tau-mediated deficits, suggesting the RNA-binding domain is required for NIPP1/sut-6's role in tau toxicity.","method":"C. elegans genetic screen, CRISPR-generated alleles, behavioral assay, tau protein quantification, neurodegeneration scoring, epistasis analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR alleles, epistasis, domain-truncation functional rescue, model organism ortholog","pmids":["37000013"],"is_preprint":false},{"year":2024,"finding":"DNA damage activates the PP1:NIPP1 holoenzyme through a Src-family kinase-mediated phosphorylation of NIPP1 at C-terminal Tyr335, causing partial dissociation of the NIPP1 C-terminus from the PP1 active site. The phospho-Y335 C-terminus then interacts with the NIPP1 N-terminus (circularization), enhancing substrate recruitment by the flanking FHA domain. Knock-in of phospho-mimetic Y335E NIPP1 causes hypo-phosphorylation of FHA ligands and accumulation of DNA double-strand breaks, confirming this activation mechanism contributes to DNA repair resolution.","method":"In vitro kinase assay (Src-family kinase), PP1 activity assay, co-immunoprecipitation, NIPP1 Y335E knock-in cells, DSB quantification","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution, phosphomimetic knock-in with functional DSB readout, molecular mechanism of circularization established","pmids":["38303113"],"is_preprint":false},{"year":2000,"finding":"NIPP-1 (Flag-tagged) co-immunoprecipitates with all three PP1 catalytic subunit isoforms (PP1α, PP1γ1, PP1δ) with similar efficiency in mammalian cells, indicating NIPP-1 interacts with PP1C through a region conserved among all three isoforms.","method":"Overexpression of Flag-tagged NIPP-1, co-immunoprecipitation with isoform-specific antibodies","journal":"The Tohoku journal of experimental medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single co-IP method, single lab, no mutagenesis or in vitro validation","pmids":["10896038"],"is_preprint":false},{"year":2022,"finding":"Conditional knockout of NIPP1 from neural precursor cells in mice leads to significantly enhanced phosphorylation of tau, altered AKT and PP1 activity, decreased MBP expression in cortex, deficits in myelinated axon percentage and compound action potential conduction, and premature lethality. These findings establish a role for NIPP1 in regulating tau phosphorylation and CNS myelination in neural development.","method":"Conditional knockout mouse model, phospho-specific tau antibody, MBP immunostaining, electrophysiology (CAP recording), axon myelination quantification","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with multiple molecular and physiological readouts, single lab","pmids":["36198882"],"is_preprint":false},{"year":2024,"finding":"Embryonic deletion of NIPP1 in keratinocytes leads to cell cycle arrest and premature senescence, with increased expression of cell cycle inhibitors p21, p16/Ink4a, p19/Arf, accumulation of senescence-associated secretory phenotype factors, and elevated DNA damage markers (γH2AX, 53BP1) in primary keratinocytes and human NIPP1-depleted HaCaT keratinocytes.","method":"Conditional knockout, primary keratinocyte culture, immunofluorescence (senescence markers, DNA damage markers), gene expression analysis","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with multiple cellular readouts and confirmation in human keratinocyte line, single lab","pmids":["38431220"],"is_preprint":false}],"current_model":"PPP1R8/NIPP1 is a multidomain nuclear regulatory subunit of protein phosphatase 1 (PP1) that, through its central RVXF-containing inhibitory domain and C-terminal PP1-binding/RNA-binding domain, potently inhibits PP1 catalytic activity while targeting the holoenzyme to RNA and phosphoprotein substrates; its N-terminal FHA domain recruits phosphorylated substrates including the splicing factors SAP155 and CDC5L, the kinase MELK, and EZH2, enabling NIPP1:PP1 to control spliceosome assembly, EZH2 phosphorylation/stability and Polycomb-mediated H3K27me3 gene silencing, DNA damage repair threshold (through R-loop accumulation and DSB repair suppression), and cell migration via Cdc42; PKA phosphorylation of NIPP1-Ser199 adjacent to the RVXF motif dissociates NIPP1 from PP1 and activates PP1 toward substrates including H3-pThr11, while DNA damage triggers Src-family kinase phosphorylation of NIPP1-Tyr335, causing allosteric PP1:NIPP1 activation through NIPP1 circularization; loss of NIPP1 in vivo causes early embryonic lethality (gastrulation stage) due to impaired cell proliferation, as well as tissue-specific defects in spermatogenesis, liver progenitor suppression, neural myelination, and keratinocyte homeostasis."},"narrative":{"mechanistic_narrative":"PPP1R8/NIPP1 is a nuclear regulatory subunit of protein phosphatase 1 (PP1) that builds substrate-selective PP1 holoenzymes controlling pre-mRNA splicing, Polycomb-mediated gene silencing, the DNA-damage response, and cell proliferation [PMID:7499293, PMID:9858469, PMID:17724462, PMID:29898919]. Through a centrally located inhibitory/PP1-binding domain (residues 143-217, with an RVxF motif at 200-203 and a ΦΦ-motif helix) it is among the most potent known PP1 inhibitors (Ki in the picomolar range) and engages PP1 at a unique, largely polar interaction surface that reshapes the holoenzyme's electrostatics and substrate selectivity [PMID:7499293, PMID:10318819, PMID:22940584]. A second C-terminal PP1-binding element overlaps an RNA-binding domain (residues 330-351) that preferentially binds U-rich RNA and targets PP1 to RNA; PP1 inhibition requires the central and C-terminal sites cooperatively [PMID:9268347, PMID:11104670, PMID:10432294]. The N-terminal FHA domain recognizes phosphorylated partners — the splicing factors SAP155/SF3b155 and CDC5L, the kinase MELK, and EZH2 — directing nuclear-speckle and spliceosomal targeting and substrate recruitment for the PP1:NIPP1 holoenzyme [PMID:10827081, PMID:11034904, PMID:12105215, PMID:14699119]. Functionally, NIPP1:PP1 controls late spliceosome assembly (the B-to-C complex transition) by promoting SAP155 dephosphorylation, then sensing its own substrate state and dissociating [PMID:11909864, PMID:18842582]. In parallel, NIPP1 recruits PP1 to chromatin in complex with PRC2 components EED and EZH2 (and HDAC2), where FHA docking onto CDK-phosphorylated EZH2 (Thr416) shields EZH2 from PP1 dephosphorylation, stabilizing EZH2 and sustaining H3K27me3 at proliferation-associated Polycomb targets [PMID:12788942, PMID:17724462, PMID:20671031, PMID:23241245, PMID:30305391]. NIPP1 also gates the DNA-damage response: covalent PP1-NIPP1 holoenzymes drive R-loop accumulation, chromatin compaction, and suppressed double-strand-break repair, and the holoenzyme is switched on by post-translational signals — PKA phosphorylation of Ser199 next to the RVxF motif and Src-family-kinase phosphorylation of Tyr335 (driving C-terminal release and N-/C-terminal circularization) both activate PP1 toward FHA-recruited and histone substrates [PMID:29898919, PMID:33939241, PMID:38303113]. Genetic loss is embryonic lethal at gastrulation from impaired proliferation, with conditional deletion producing tissue-specific defects in spermatogenesis, CNS myelination, and keratinocyte homeostasis [PMID:15199142, PMID:29042623, PMID:36198882, PMID:38431220].","teleology":[{"year":1995,"claim":"Established NIPP1 as a discrete, potent nuclear inhibitor of PP1 and localized its inhibitory activity to a defined central segment, answering what kind of regulator it is.","evidence":"cDNA cloning from bovine thymus with recombinant-fragment PP1 inhibition and phosphorylation assays","pmids":["7499293","8390458"],"confidence":"High","gaps":["Did not define the structural basis of PP1 binding","Cellular substrates of the holoenzyme unknown"]},{"year":1997,"claim":"Mapped the kinase sites (PKA Ser178/Ser199, CK2 Thr161/Ser204) and showed phosphorylation regulates inhibitory potency, but within the holoenzyme activates PP1 without releasing NIPP1 — clarifying how the inhibitor is tuned.","evidence":"Baculovirus-expressed protein, tryptic phosphopeptide sequencing, quantitative PP1 inhibition assays","pmids":["9407077"],"confidence":"High","gaps":["In vivo relevance of each phosphosite not established","Substrate consequences not measured"]},{"year":1997,"claim":"Revealed an unexpected RNA-binding activity in the C-terminus that targets PP1 to RNA, expanding NIPP1 from a simple inhibitor to a substrate-targeting subunit.","evidence":"North-Western, UV cross-linking, RNA mobility shift, poly(U)-Sepharose chromatography","pmids":["9268347"],"confidence":"High","gaps":["Physiological RNA targets not identified","Functional consequence of RNA-targeting of PP1 untested at this stage"]},{"year":1999,"claim":"Dissected the modular architecture — a central inhibitory/RVxF site and a separate C-terminal PP1-binding/RNA-binding/cryptic endoribonuclease region — defining how distinct domains cooperate, and placed NIPP1:PP1 in nuclear speckles controlling pre-mRNA splicing.","evidence":"Yeast two-hybrid, far-Western, peptide competition, deletion fragments, immunodepletion with in vitro splicing assay","pmids":["10318819","11104670","10432294","9858469"],"confidence":"High","gaps":["Direct splicing substrates of PP1:NIPP1 not yet identified","Physiological role of the latent endoribonuclease activity unknown"]},{"year":2000,"claim":"Identified the FHA domain as a phospho-dependent recruiter (CDC5L) and defined separable nuclear-import (central NLS) versus speckle-targeting (FHA) signals, explaining how NIPP1 is positioned and how it selects substrates.","evidence":"Yeast two-hybrid, co-IP/co-purification, EGFP-fusion live-cell microscopy, deletion mutagenesis","pmids":["10827081","11034904"],"confidence":"High","gaps":["Full set of FHA ligands not yet enumerated","Whether FHA recruitment couples to PP1 catalysis unresolved here"]},{"year":2002,"claim":"Showed NIPP1 is a bona fide spliceosomal component acting at the B-to-C transition via its FHA domain, and identified SAP155 and MELK as additional phospho-dependent FHA ligands linking splicing control to cell-cycle kinases.","evidence":"In vitro spliceosome assembly assays, co-IP, kinase-inhibitor and phosphosite-mutant analyses","pmids":["11909864","12105215","14699119"],"confidence":"High","gaps":["Direct dephosphorylation of spliceosomal substrates not yet demonstrated","Mechanism connecting MELK binding to splicing inhibition incompletely defined"]},{"year":2003,"claim":"Connected NIPP1 to Polycomb silencing by identifying EED interaction and transcriptional repressor activity, opening a chromatin role distinct from splicing.","evidence":"Yeast two-hybrid, co-IP, transcription reporter assays, domain mutagenesis","pmids":["12788942"],"confidence":"Medium","gaps":["Requirement for PP1 catalysis in repression not established here","Genome-wide target spectrum unknown at this stage"]},{"year":2004,"claim":"Demonstrated NIPP1 is essential for cell proliferation and early development, establishing its physiological indispensability.","evidence":"Constitutive knockout mice, blastocyst outgrowth, RNAi, proliferation assays","pmids":["15199142"],"confidence":"High","gaps":["Molecular cause of the proliferation defect not pinpointed","No viable null cell line, limiting mechanistic dissection"]},{"year":2008,"claim":"Provided the mechanistic logic of FHA-directed substrate dephosphorylation: NIPP1 senses hyperphosphorylated SAP155, recruits PP1, drives dephosphorylation, then releases — defining it as a substrate-cycling sensor.","evidence":"In vitro dephosphorylation reconstitution, co-IP, siRNA, truncation-mutant splicing assays","pmids":["18842582"],"confidence":"High","gaps":["Generality of the sense-and-release cycle to other FHA ligands untested here"]},{"year":2012,"claim":"Resolved the structural basis of PP1 binding (intrinsically disordered domain forming a helix at a polar ΦΦ-motif site) and unified the chromatin model: FHA docking on CDK-phosphorylated EZH2 shields EZH2 from PP1, stabilizing it and retargeting Polycomb silencing of proliferation genes; also linked PP1:NIPP1 to Cdc42-dependent directional migration.","evidence":"NMR/crystallography with mutagenesis; co-IP, phospho-antibody, ChIP/DamID/ChIP-seq, electrotaxis with Cdc42 assays","pmids":["22940584","23241245","20671031","22815811"],"confidence":"High","gaps":["How holoenzyme assembly is choreographed in vivo across substrates not fully integrated","Migration mechanism (PP1:NIPP1 substrates upstream of Cdc42) undefined"]},{"year":2017,"claim":"Extended the EZH2-stabilization model in vivo: testis-specific deletion causes germ-cell loss, and CDK-site EZH2 hyperphosphorylation leads to its degradation and loss of H3K27me3, establishing PP1:NIPP1 as an EZH2 stabilizer in a physiological setting.","evidence":"Conditional knockout, EZH2 phosphosite alanine mutants, protein half-life, H3K27me3 ChIP, ex vivo testis culture","pmids":["29042623","30305391"],"confidence":"High","gaps":["Tissue-specific differences in the proliferation requirement not explained","Other dephosphorylation substrates contributing to germ-cell loss not excluded"]},{"year":2018,"claim":"Defined a DNA-damage/genome-stability function: an engineered hyperactive PP1-NIPP1 holoenzyme drives R-loop accumulation, chromatin compaction, and suppressed DSB repair, requiring both catalysis and FHA recruitment.","evidence":"Inducible PP1-NIPP1 fusion cell lines, R-loop and DSB assays, chromatin compaction and gene-expression readouts","pmids":["29898919"],"confidence":"High","gaps":["Direct repair-pathway substrates dephosphorylated by the holoenzyme not identified","Whether endogenous (non-fused) NIPP1 acts the same way needed validation"]},{"year":2024,"claim":"Identified the activating switches of the holoenzyme: PKA phosphorylation of Ser199 dissociates NIPP1 to activate PP1γ toward H3-pThr11, and DNA-damage-triggered Src-family phosphorylation of Tyr335 releases the C-terminus and drives N-/C-terminal circularization to boost FHA-mediated substrate recruitment.","evidence":"In vitro PP1 activity/kinase assays, co-IP with phosphosites, Y335E knock-in cells, DSB quantification, ChIP","pmids":["33939241","38303113"],"confidence":"Medium","gaps":["In vivo kinase responsible for each event under physiological DNA damage not fully defined","How circularization and dissociation are coordinated across substrate classes unresolved"]},{"year":2023,"claim":"Implicated the NIPP1 RNA-binding domain in proteotoxicity: loss or C-terminal truncation of the ortholog suppresses tau toxicity, and conditional CNS deletion alters tau phosphorylation and impairs myelination/conduction, linking NIPP1 to neuronal homeostasis.","evidence":"C. elegans CRISPR alleles, epistasis, behavioral/neurodegeneration scoring; mouse neural conditional knockout with phospho-tau, MBP, and electrophysiology","pmids":["37000013","36198882"],"confidence":"Medium","gaps":["Molecular substrate connecting NIPP1 to tau phosphorylation unidentified","Cross-species relevance of the RNA-binding-domain requirement uncertain"]},{"year":2024,"claim":"Demonstrated cell-type-specific proliferation control in vivo: keratinocyte deletion triggers cell-cycle arrest, senescence, and DNA damage marker accumulation, linking NIPP1 loss to genome-stress phenotypes.","evidence":"Conditional knockout, primary and HaCaT keratinocytes, senescence/DNA-damage immunofluorescence, gene expression","pmids":["38431220"],"confidence":"Medium","gaps":["Causal pathway from NIPP1 loss to senescence not mechanistically resolved","Relationship to the EZH2/Polycomb and R-loop functions not directly tested"]},{"year":null,"claim":"How the distinct activating signals (PKA-Ser199, SFK-Tyr335) and substrate-recruitment events are integrated to choose between splicing, Polycomb, and DNA-repair outputs in a given cell context remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified in vivo map of which substrates dominate per tissue","Direct repair and migration substrates of PP1:NIPP1 unidentified","Physiological role of the latent C-terminal endoribonuclease activity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,4,17,26]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2,4,6]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3,6,7]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,11,17]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[7]}],"localization":[{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[5,9]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,9]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[18,20]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[5,10,17]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[15,18,20,26]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[25,29]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[13,16,27]}],"complexes":["PP1:NIPP1 holoenzyme","spliceosome","PRC2 (NIPP1·EED·EZH2)"],"partners":["PPP1CA","PPP1CC","SF3B1","CDC5L","MELK","EZH2","EED","HDAC2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q12972","full_name":"Nuclear inhibitor of protein phosphatase 1","aliases":["Protein phosphatase 1 regulatory inhibitor subunit 8"],"length_aa":351,"mass_kda":38.5,"function":"Inhibitor subunit of the major nuclear protein phosphatase-1 (PP-1). It has RNA-binding activity but does not cleave RNA and may target PP-1 to RNA-associated substrates. May also be involved in pre-mRNA splicing. Binds DNA and might act as a transcriptional repressor. Seems to be required for cell proliferation Isoform Gamma is a site-specific single-strand endoribonuclease that cleaves single strand RNA 3' to purines and pyrimidines in A+U-rich regions. It generates 5'-phosphate termini at the site of cleavage. This isoform does not inhibit PP-1. May be implicated in mRNA splicing","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q12972/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/PPP1R8","classification":"Common Essential","n_dependent_lines":1194,"n_total_lines":1208,"dependency_fraction":0.9884105960264901},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PRPF4B","stoichiometry":4.0},{"gene":"CPSF6","stoichiometry":0.2},{"gene":"DDX39B","stoichiometry":0.2},{"gene":"RBM39","stoichiometry":0.2},{"gene":"SF3A1","stoichiometry":0.2},{"gene":"SNRPA","stoichiometry":0.2},{"gene":"SNRPB","stoichiometry":0.2},{"gene":"SNRPC","stoichiometry":0.2},{"gene":"SNRPF","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PPP1R8","total_profiled":1310},"omim":[{"mim_id":"602999","title":"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3C; PPP1R3C","url":"https://www.omim.org/entry/602999"},{"mim_id":"602636","title":"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 8; PPP1R8","url":"https://www.omim.org/entry/602636"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nuclear speckles","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PPP1R8"},"hgnc":{"alias_symbol":["ard-1","NIPP-1","PRO2047","ARD1","NIPP1"],"prev_symbol":[]},"alphafold":{"accession":"Q12972","domains":[{"cath_id":"2.60.200.20","chopping":"26-127","consensus_level":"medium","plddt":93.6976,"start":26,"end":127}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q12972","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q12972-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q12972-F1-predicted_aligned_error_v6.png","plddt_mean":67.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PPP1R8","jax_strain_url":"https://www.jax.org/strain/search?query=PPP1R8"},"sequence":{"accession":"Q12972","fasta_url":"https://rest.uniprot.org/uniprotkb/Q12972.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q12972/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q12972"}},"corpus_meta":[{"pmid":"7499293","id":"PMC_7499293","title":"Molecular cloning of NIPP-1, a nuclear inhibitor of protein phosphatase-1, reveals homology with polypeptides involved in RNA processing.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7499293","citation_count":100,"is_preprint":false},{"pmid":"10827081","id":"PMC_10827081","title":"NIPP1-mediated interaction of protein phosphatase-1 with CDC5L, a regulator of pre-mRNA splicing and mitotic entry.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10827081","citation_count":95,"is_preprint":false},{"pmid":"14699119","id":"PMC_14699119","title":"Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14699119","citation_count":86,"is_preprint":false},{"pmid":"10318819","id":"PMC_10318819","title":"Molecular determinants of nuclear protein phosphatase-1 regulation by NIPP-1.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10318819","citation_count":75,"is_preprint":false},{"pmid":"17724462","id":"PMC_17724462","title":"The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17724462","citation_count":71,"is_preprint":false},{"pmid":"22940584","id":"PMC_22940584","title":"The molecular basis for substrate specificity of the nuclear NIPP1:PP1 holoenzyme.","date":"2012","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/22940584","citation_count":68,"is_preprint":false},{"pmid":"8390458","id":"PMC_8390458","title":"Inactivation of nuclear inhibitory polypeptides of protein phosphatase-1 (NIPP-1) by protein kinase A.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8390458","citation_count":63,"is_preprint":false},{"pmid":"12105215","id":"PMC_12105215","title":"Phosphorylation-dependent interaction between the splicing factors SAP155 and NIPP1.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12105215","citation_count":63,"is_preprint":false},{"pmid":"11104670","id":"PMC_11104670","title":"The C-terminus of NIPP1 (nuclear inhibitor of protein phosphatase-1) contains a novel binding site for protein phosphatase-1 that is controlled by tyrosine phosphorylation and RNA binding.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11104670","citation_count":59,"is_preprint":false},{"pmid":"9858469","id":"PMC_9858469","title":"Nuclear organisation of NIPP1, a regulatory subunit of protein phosphatase 1 that associates with pre-mRNA splicing factors.","date":"1999","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/9858469","citation_count":59,"is_preprint":false},{"pmid":"11034904","id":"PMC_11034904","title":"Nuclear and subnuclear targeting sequences of the protein phosphatase-1 regulator NIPP1.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11034904","citation_count":49,"is_preprint":false},{"pmid":"9407077","id":"PMC_9407077","title":"Properties and phosphorylation sites of baculovirus-expressed nuclear inhibitor of protein phosphatase-1 (NIPP-1).","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9407077","citation_count":48,"is_preprint":false},{"pmid":"18842582","id":"PMC_18842582","title":"Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155).","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18842582","citation_count":48,"is_preprint":false},{"pmid":"7524097","id":"PMC_7524097","title":"ard-1: a human gene that reverses the effects of temperature-sensitive and deletion mutations in the Escherichia coli rne gene and encodes an activity producing RNase E-like cleavages.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7524097","citation_count":44,"is_preprint":false},{"pmid":"23241245","id":"PMC_23241245","title":"NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23241245","citation_count":41,"is_preprint":false},{"pmid":"11909864","id":"PMC_11909864","title":"The protein phosphatase-1 regulator NIPP1 is also a splicing factor involved in a late step of spliceosome assembly.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11909864","citation_count":40,"is_preprint":false},{"pmid":"8473324","id":"PMC_8473324","title":"ARD 1, a 64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation factor domain.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8473324","citation_count":37,"is_preprint":false},{"pmid":"20671031","id":"PMC_20671031","title":"The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20671031","citation_count":35,"is_preprint":false},{"pmid":"9268347","id":"PMC_9268347","title":"NIPP-1, a nuclear inhibitory subunit of protein phosphatase-1, has RNA-binding properties.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9268347","citation_count":34,"is_preprint":false},{"pmid":"9153239","id":"PMC_9153239","title":"ARD-1 cDNA from human cells encodes a site-specific single-strand endoribonuclease that functionally resembles Escherichia coli RNase E.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9153239","citation_count":32,"is_preprint":false},{"pmid":"12788942","id":"PMC_12788942","title":"The protein phosphatase-1 (PP1) regulator, nuclear inhibitor of PP1 (NIPP1), interacts with the polycomb group protein, embryonic ectoderm development (EED), and functions as a transcriptional repressor.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12788942","citation_count":30,"is_preprint":false},{"pmid":"15199142","id":"PMC_15199142","title":"The nuclear scaffold protein NIPP1 is essential for early embryonic development and cell proliferation.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15199142","citation_count":28,"is_preprint":false},{"pmid":"22815811","id":"PMC_22815811","title":"A role for PP1/NIPP1 in steering migration of human cancer cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22815811","citation_count":24,"is_preprint":false},{"pmid":"12358598","id":"PMC_12358598","title":"Functional interaction between nuclear inhibitor of protein phosphatase type 1 (NIPP1) and protein phosphatase type 1 (PP1) in Drosophila: consequences of over-expression of NIPP1 in flies and suppression by co-expression of PP1.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12358598","citation_count":22,"is_preprint":false},{"pmid":"16705796","id":"PMC_16705796","title":"Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line.","date":"2005","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/16705796","citation_count":22,"is_preprint":false},{"pmid":"29898919","id":"PMC_29898919","title":"Overexpression of PP1-NIPP1 limits the capacity of cells to repair DNA double-strand breaks.","date":"2018","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/29898919","citation_count":18,"is_preprint":false},{"pmid":"16826568","id":"PMC_16826568","title":"Regulation of protein phosphatase 1gamma activity in hypoxia through increased interaction with NIPP1: implications for cellular metabolism.","date":"2006","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16826568","citation_count":18,"is_preprint":false},{"pmid":"10432294","id":"PMC_10432294","title":"Mapping of the RNA-binding and endoribonuclease domains of NIPP1, a nuclear targeting subunit of protein phosphatase 1.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10432294","citation_count":16,"is_preprint":false},{"pmid":"29042623","id":"PMC_29042623","title":"The protein phosphatase 1 regulator NIPP1 is essential for mammalian spermatogenesis.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29042623","citation_count":15,"is_preprint":false},{"pmid":"30305391","id":"PMC_30305391","title":"The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30305391","citation_count":14,"is_preprint":false},{"pmid":"10428496","id":"PMC_10428496","title":"Identification of MYPT1 and NIPP1 as subunits of protein phosphatase 1 in rat liver cytosol.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10428496","citation_count":14,"is_preprint":false},{"pmid":"25907536","id":"PMC_25907536","title":"Protein phosphatase PP1-NIPP1 activates mesenchymal genes in HeLa cells.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/25907536","citation_count":13,"is_preprint":false},{"pmid":"17804093","id":"PMC_17804093","title":"The transcriptional repression by NIPP1 is mediated by Polycomb group proteins.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17804093","citation_count":11,"is_preprint":false},{"pmid":"10103062","id":"PMC_10103062","title":"Organization and alternate splice products of the gene encoding nuclear inhibitor of protein phosphatase-1 (NIPP-1).","date":"1999","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10103062","citation_count":10,"is_preprint":false},{"pmid":"10717244","id":"PMC_10717244","title":"Increased expression of NIPP-1 mRNA correlates positively with malignant phenotype in rat hepatomas.","date":"2000","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10717244","citation_count":9,"is_preprint":false},{"pmid":"27068806","id":"PMC_27068806","title":"Brief Report: The Deletion of the Phosphatase Regulator NIPP1 Causes Progenitor Cell Expansion in the Adult Liver.","date":"2016","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/27068806","citation_count":9,"is_preprint":false},{"pmid":"9249054","id":"PMC_9249054","title":"Inhibition of translation by mRNA encoding NIPP-1, a nuclear inhibitor of protein phosphatase-1.","date":"1997","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9249054","citation_count":8,"is_preprint":false},{"pmid":"33939241","id":"PMC_33939241","title":"PP1 regulatory subunit NIPP1 regulates transcription of E2F1 target genes following DNA damage.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33939241","citation_count":8,"is_preprint":false},{"pmid":"32123159","id":"PMC_32123159","title":"Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1.","date":"2020","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32123159","citation_count":8,"is_preprint":false},{"pmid":"10564811","id":"PMC_10564811","title":"Alternative splicing regulates the production of ARD-1 endoribonuclease and NIPP-1, an inhibitor of protein phosphatase-1, as isoforms encoded by the same gene.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10564811","citation_count":8,"is_preprint":false},{"pmid":"37000013","id":"PMC_37000013","title":"Sut-6/NIPP1 modulates tau toxicity.","date":"2023","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37000013","citation_count":7,"is_preprint":false},{"pmid":"21653881","id":"PMC_21653881","title":"Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21653881","citation_count":6,"is_preprint":false},{"pmid":"31972250","id":"PMC_31972250","title":"Phosphatase Regulator NIPP1 Restrains Chemokine-Driven Skin Inflammation.","date":"2020","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/31972250","citation_count":5,"is_preprint":false},{"pmid":"38303113","id":"PMC_38303113","title":"DNA damage-induced allosteric activation of protein phosphatase PP1:NIPP1 through Src kinase-induced circularization of NIPP1.","date":"2024","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/38303113","citation_count":4,"is_preprint":false},{"pmid":"36198882","id":"PMC_36198882","title":"Nuclear Inhibitor of Protein Phosphatase 1 (NIPP1) Regulates CNS Tau Phosphorylation and Myelination During Development.","date":"2022","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/36198882","citation_count":3,"is_preprint":false},{"pmid":"10896038","id":"PMC_10896038","title":"Broad specificity in binding of NIPP-1, nuclear inhibitor of protein phosphatase-1, to PP1 isoforms in vivo.","date":"2000","source":"The Tohoku journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10896038","citation_count":3,"is_preprint":false},{"pmid":"38431220","id":"PMC_38431220","title":"Embryonic NIPP1 Depletion in Keratinocytes Triggers a Cell Cycle Arrest and Premature Senescence in Adult Mice.","date":"2024","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/38431220","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23021,"output_tokens":9494,"usd":0.105736,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19529,"output_tokens":5717,"usd":0.120285,"stage2_stop_reason":"end_turn"},"total_usd":0.226021,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"NIPP-1 was cloned from bovine thymus as a 351-residue nuclear protein (38.5 kDa calculated mass) that potently inhibits PP1 catalytic subunit; its central third (residues 143-217) is sufficient for PP1 inhibition (IC50 ~0.3 nM), and phosphorylation by PKA or CK2 reduces its inhibitory potency. The C-terminus of NIPP-1 is nearly identical to the human ard-1 protein, and their mRNAs are generated by alternative splicing of the same pre-mRNA. Western blot showed a single nuclear polypeptide of 47 kDa.\",\n      \"method\": \"cDNA cloning, bacterially expressed recombinant protein PP1 inhibition assay, phosphorylation assay, Western blot, Northern analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of PP1 inhibition with recombinant domain fragments, mutagenesis/phosphorylation functional assays, replicated in subsequent papers\",\n      \"pmids\": [\"7499293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"NIPP-1a and NIPP-1b (16-18 kDa isoforms) are excellent substrates for PKA (Km = 0.1 µM); maximal PKA phosphorylation (1.5 mol phosphate/mol NIPP-1) caused an 8-fold increase in IC50 for PP1 inhibition and decreased binding of NIPP-1 to immobilized PP1. Dephosphorylation by PP2A (but not PP1) reactivated NIPP-1. The nuclear PP1 holoenzyme PP-1Nα containing NIPP-1 was activated 6-fold by PKA, opposite to the known inhibition of cytoplasmic PP1 by PKA.\",\n      \"method\": \"In vitro kinase assay, PP1 inhibition assay, immobilized PP1 binding assay, phosphatase reactivation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase/phosphatase reconstitution with quantitative IC50 measurements, multiple orthogonal methods\",\n      \"pmids\": [\"8390458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Baculovirus-expressed NIPP-1 is a potent PP1 inhibitor (Ki = 9.9 pM). PKA phosphorylates Ser178 and Ser199; CK2 phosphorylates Thr161 and Ser204. At physiological ionic strength, phosphorylation by PKA or CK2 drastically reduced inhibitory potency of free NIPP-1. Phosphorylation of NIPP-1 within the PP1:NIPP-1 holoenzyme activated the holoenzyme without releasing NIPP-1.\",\n      \"method\": \"Baculovirus expression, in vitro kinase assay, tryptic phosphopeptide sequencing, phosphoamino acid analysis, PP1 inhibition assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — recombinant protein, site-specific phosphorylation mapped by peptide sequencing, quantitative enzymatic assays\",\n      \"pmids\": [\"9407077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NIPP-1 displays RNA-binding properties, preferentially binding U-rich sequences including AUUUA motifs; it also binds single-stranded DNA but not double-stranded DNA. The C-terminus of NIPP-1 mediates RNA binding. RNA binding was not affected by PKA or CK2 phosphorylation. PP1 catalytic subunit alone does not bind poly(U)-Sepharose but binds tightly after complexation with NIPP-1, suggesting NIPP-1 targets PP1 to RNA.\",\n      \"method\": \"North-Western analysis, UV cross-linking, RNA mobility-shift assay, poly(U)-Sepharose chromatography\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal RNA-binding assays with recombinant protein, antibody competition, replicated in subsequent mapping studies\",\n      \"pmids\": [\"9268347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The PP1-binding and inhibitory function of NIPP-1 maps to the central domain (residues 143-217), with the inhibitory core narrowed to residues 191-200. A second non-inhibitory PP1-binding site contains the RVXF motif (residues 200-203); V201A and F203A substitutions or phosphorylation of Ser199 or Ser204 abolished PP1C binding at this site. The central domain peptide competed for PP1 inhibition by full-length NIPP-1 and inhibitor-1/inhibitor-2.\",\n      \"method\": \"Yeast two-hybrid, co-sedimentation, far-Western (digoxigenin-conjugated PP1C), synthetic peptide competition assay, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (yeast 2-hybrid, far-Western, peptide competition, mutagenesis) in a single rigorous study\",\n      \"pmids\": [\"10318819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NIPP1 exhibits a speckled nucleoplasmic distribution co-localizing with pre-mRNA splicing factors (including Sm proteins) in nuclear speckles. Sm splicing factor co-immunoprecipitates with NIPP1 from nuclear extracts. Immunodepletion of NIPP1 from nuclear extracts, or addition of a dominant-negative mutant lacking a functional PP1-binding site, greatly reduces pre-mRNA splicing activity in vitro, implicating the NIPP1-PP1 complex in splicing control.\",\n      \"method\": \"Immunofluorescence, co-immunoprecipitation, immunodepletion, in vitro splicing assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, immunodepletion with functional readout (splicing assay), co-localization; replicated in subsequent studies\",\n      \"pmids\": [\"9858469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The C-terminal region of NIPP1 (residues 311-351) contains an additional PP1 inhibitory binding site with inhibitory core at residues 331-337. This site is regulated by tyrosine phosphorylation of Tyr335 (by Lyn kinase, but only in the presence of RNA) and by RNA addition, both of which decrease inhibitory potency. The RNA-binding domain maps to C-terminal residues 330-351. Full-length NIPP1 requires both the central and C-terminal PP1-binding domains cooperatively for inhibition of myelin basic protein dephosphorylation.\",\n      \"method\": \"Site-directed mutagenesis, in vitro PP1 inhibition assay, in vitro kinase assay with Lyn\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and kinase assay, multiple sites mapped, single lab\",\n      \"pmids\": [\"11104670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The RNA-binding domain of NIPP1 maps to C-terminal residues 330-351; a synthetic peptide of this sequence equals intact NIPP1 in RNA-binding affinity. An alternatively spliced fragment NIPP1(225-351)/Ard1 displays single-strand Mg2+-dependent endoribonuclease activity. Full-length NIPP1 and NIPP1(143-351) lack endoribonuclease activity, indicating the central domain restrains this activity. The endoribonuclease catalytic site also resides in the C-terminal 22 residues.\",\n      \"method\": \"Recombinant fragment analysis, RNA-binding assay, endoribonuclease activity assay with recombinant fragments\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution with mapped deletion fragments, multiple domain constructs tested\",\n      \"pmids\": [\"10432294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The N-terminal FHA (Forkhead-Associated) domain of NIPP1 interacts with CDC5L (a regulator of G2/M progression and pre-mRNA splicing) in a phosphorylation-dependent manner; cyclin E-Cdk2 phosphorylation of CDC5L enables this interaction. CDC5L, NIPP1, and PP1 form a complex in rat liver nuclear extracts demonstrated by co-immunoprecipitation and co-purification. CDC5L and NIPP1 co-localize in nuclear speckles. The FHA domain blocks beta-globin pre-mRNA splicing in nuclear extracts, and an FHA mutation abolishing CDC5L interaction also cancels the anti-splicing effect.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, co-purification, immunofluorescence co-localization, in vitro splicing assay, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP/co-purification, FHA domain mutagenesis linked to functional splicing defect, co-localization\",\n      \"pmids\": [\"10827081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Nuclear and subnuclear targeting of NIPP1 are mediated by distinct sequences: active nuclear import requires two independent NLS signals in the central domain (which partially overlap with PP1-binding sites), while concentration in nuclear speckles requires the FHA domain in the N-terminus. The FHA domain is also required for nuclear retention when active transport is blocked.\",\n      \"method\": \"EGFP fusion protein expression in HeLa/COS-1 cells, deletion mutagenesis, live-cell fluorescence microscopy\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic deletion mutant analysis in two cell lines, direct localization with functional domain mapping\",\n      \"pmids\": [\"11034904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NIPP1 is a component of spliceosomes in HeLa cell splicing extracts, requiring a functional FHA domain for spliceosomal interaction. Dominant-negative NIPP1 mutants lacking residues 225-329 block splicing at the transition between the B-complex and C-complex (a late phase of spliceosome assembly). This spliceosomal function is independent of PP1-binding and RNA-binding capacity.\",\n      \"method\": \"In vitro splicing assay, spliceosome complex analysis, site-directed mutagenesis, HeLa nuclear extracts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro spliceosome assembly assay with defined mutants, domain dissection, functional readout\",\n      \"pmids\": [\"11909864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The FHA domain of NIPP1 interacts in vitro and in vivo with the splicing factor SAP155/SF3b(155) in a phosphorylation-dependent manner, specifically requiring phosphorylation of TP dipeptide motifs in SAP155 by Ca2+-dependent, roscovitine-sensitive (CDK) kinases. Various phosphorylated TP motifs compete for the same FHA binding site. SAP155 phosphorylation is dramatically increased during mitosis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, mutagenesis, kinase inhibitor treatment, mitotic cell analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro and in vivo co-IP, competition assays, mutagenesis, cell-cycle context established\",\n      \"pmids\": [\"12105215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The FHA domain of NIPP1 interacts with the cell cycle-regulated kinase MELK (maternal embryonic leucine zipper kinase), dependent on phosphorylation of Thr-478 of MELK and increased in mitotically arrested cells. Recombinant MELK (including kinase-dead mutant) inhibits an early step of spliceosome assembly in nuclear extracts, but a T478A MELK mutant that cannot bind NIPP1 lacks this splicing inhibition, indicating NIPP1 mediates MELK's inhibitory effect on splicing.\",\n      \"method\": \"Co-immunoprecipitation, in vitro spliceosome assembly assay, recombinant MELK protein, kinase-dead and phosphosite mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional spliceosome assay with phosphosite mutant epistasis, co-IP, recombinant proteins\",\n      \"pmids\": [\"14699119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NIPP1 interacts with the Polycomb group protein EED (embryonic ectoderm development) via two interaction domains in the central and C-terminal thirds of NIPP1, identified by yeast two-hybrid and confirmed in vivo. (d)G-rich nucleic acids potentiate the NIPP1-EED interaction and also decrease NIPP1's potency as a PP1 inhibitor, but do not prevent formation of a ternary NIPP1·EED·PP1 complex. NIPP1 acts as a transcriptional repressor of targeted genes through its EED interaction domain; histone deacetylase 2 (HDAC2) is also present in a complex with NIPP1.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, transcription reporter assay, domain mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — yeast 2-hybrid plus co-IP, transcription repression assay, single lab\",\n      \"pmids\": [\"12788942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NIPP1 knockout mice (NIPP1-/-) show severely retarded growth at E6.5 and are resorbed by E8.5; lethality is not associated with increased apoptosis but correlates with impaired cell proliferation. Blastocyst outgrowth and siRNA knockdown in cultured cells confirm an essential role for NIPP1 in cell proliferation. No viable NIPP1-/- cell lines could be established.\",\n      \"method\": \"Homologous recombination knockout, blastocyst outgrowth, RNA interference knockdown, cell proliferation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout in mice with multiple confirmatory approaches (blastocyst outgrowth, RNAi), clear proliferation phenotype\",\n      \"pmids\": [\"15199142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NIPP1 is required for EZH2-mediated trimethylation of histone H3 on Lys27 (H3K27me3) both during embryonic development and in proliferating cells. Knockdown of NIPP1 reduces H3K27me3 globally; NIPP1 and EZH2 silence a common set of genes; NIPP1 is associated with Polycomb target genes and H3K27me3-enriched regions. Knockdown of either NIPP1 or EZH2 causes loss of H3K27me3 at target loci.\",\n      \"method\": \"RNAi knockdown, ChIP, gene-expression profiling, NIPP1-deficient cells\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, gene-expression profiling, and genetic depletion with multiple orthogonal readouts\",\n      \"pmids\": [\"17724462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Transcriptional repression by NIPP1 is mediated by PRC2 components EED and EZH2: RNAi knockdown of EED or EZH2, or overexpression of catalytically dead EZH2, alleviates NIPP1-mediated repression. NIPP1 is present in a complex with EED and EZH2 in vivo and has distinct binding sites for these proteins.\",\n      \"method\": \"RNAi knockdown, co-immunoprecipitation, transcription reporter assay, catalytic-dead EZH2 mutant\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — co-IP plus functional reporter assay plus genetic depletion, single lab\",\n      \"pmids\": [\"17804093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NIPP1 recruits PP1 to SAP155 (Sap155) via its FHA domain, which recognizes hyperphosphorylated Sap155, and promotes Sap155 dephosphorylation. NIPP1 acts as a molecular sensor: it stimulates Sap155 dephosphorylation by PP1 in vitro by facilitating their interaction, then dissociates from Sap155 after dephosphorylation. A C-terminally truncated NIPP1 (NIPP1-ΔC) forms a hyperactive holoenzyme with PP1 that dramatically reduces Sap155 hyperphosphorylation and inhibits splicing.\",\n      \"method\": \"Co-immunoprecipitation, in vitro dephosphorylation assay, siRNA knockdown, overexpression of truncation mutants, splicing assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro reconstitution of dephosphorylation, multiple mutant constructs, functional splicing readout, siRNA confirmation\",\n      \"pmids\": [\"18842582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NIPP1 forms a complex with PP1 and PRC2 components (including EZH2) on chromatin. Knockdown of NIPP1 or PP1 reduces EZH2 association with a subset of its target genes; overexpression of NIPP1 retargets EZH2 from fully repressed to partially active PcG targets. A PP1-binding mutant of NIPP1 (NIPP1m) does not cause EZH2 redistribution and shows deficient chromatin binding at Polycomb target loci (DamID mapping). NIPP1 associates with multiple PcG target genes including the Homeobox A cluster.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, DamID chromatin mapping, siRNA knockdown, overexpression\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, DamID genome-wide, co-IP, PP1-binding mutant epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"20671031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal/NMR structure of the PP1-binding domain of NIPP1 shows it is intrinsically disordered and binds PP1 by forming an α-helix that engages PP1 at a unique interaction site using polar (not hydrophobic) contacts. The structure reveals a shared PP1 interaction site outside the RVxF motif, the ΦΦ motif. NIPP1:PP1 substrate selectivity is determined by altered electrostatics and enhanced substrate localization.\",\n      \"method\": \"Structural determination (NMR/crystallography with functional validation), mutagenesis, substrate specificity assay\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structure determination with functional validation of interaction mechanism and substrate selectivity\",\n      \"pmids\": [\"22940584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CDK-mediated phosphorylation of EZH2 at Thr416 creates a docking site for the FHA domain of NIPP1. Recruited NIPP1 inhibits PP1-mediated dephosphorylation of EZH2, thereby enabling net EZH2 phosphorylation. A NIPP1-binding mutant of EZH2 is hypophosphorylated; NIPP1 knockdown reduces endogenous EZH2 phosphorylation; PP1 loss is associated with EZH2 hyperphosphorylation. Genome-wide promoter profiling shows NIPP1-binding mutant EZH2 has deficient association with ~one-third of Polycomb target genes (proliferation-related). PP1 is identified as an EZH2 phosphatase.\",\n      \"method\": \"Co-immunoprecipitation, phospho-specific antibody, siRNA knockdown, genome-wide ChIP-seq/promoter binding profiling, site-directed mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-IP, phospho-antibody, genome-wide profiling, mutagenesis), mechanistic chain established\",\n      \"pmids\": [\"23241245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PP1/NIPP1 regulates directional cell migration: genetic disruption of PP1 or NIPP1 decreases directional migration; inducible NIPP1 expression switches HeLa directional response from cathodal to anodal in a PP1-dependent manner. PP1:NIPP1 upregulates Cdc42 GTPase signaling; pharmacological Cdc42 inhibition in NIPP1-overexpressing cells recovers cathodal migration.\",\n      \"method\": \"Electrotaxis assay, siRNA knockdown, inducible overexpression, Cdc42 activity assay, pharmacological inhibition\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — functional migration assay with genetic and pharmacological perturbations, PP1-dependency established, Cdc42 pathway placement\",\n      \"pmids\": [\"22815811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In hypoxia, PP1γ activity is inhibited at least in part through increased association with NIPP1, an event dependent on decreased basal cAMP/PKA signaling. A dominant-negative NIPP1 construct rescues CREB activity and CREB-dependent transcription in hypoxia, demonstrating NIPP1 mediates decreased PP1γ activity and altered metabolic gene expression under hypoxic conditions.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative NIPP1 expression, reporter assay, ATP measurement\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — co-IP and dominant-negative functional assay, single lab, PKA-dependency established\",\n      \"pmids\": [\"16826568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Mild stable overexpression of NIPP1 in HeLa cells causes a massive induction of mesenchymal genes (smooth/cardiac-muscle and matrix markers), formation of actin-based stress fibers and retracting filopodia, and reduced proliferation. This mesenchymal transition requires functional substrate-binding (FHA) and PP1-binding domains of NIPP1, indicating it involves selective dephosphorylation of PP1:NIPP1 substrates.\",\n      \"method\": \"Stable inducible overexpression, gene expression analysis, immunofluorescence (actin cytoskeleton), domain mutagenesis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — domain mutant dissection with transcriptomic and cytoskeletal readouts, single lab\",\n      \"pmids\": [\"25907536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Inducible, testis-specific NIPP1 knockout in adult mice results in gradual loss of germ cells (Sertoli-cell only phenotype), decreased proliferation and survival of spermatogenic lineage cells including undifferentiated spermatogonia. NIPP1 removal from cultured testis slices and isolated germ cells also reduces proliferation, indicating a testis-intrinsic requirement.\",\n      \"method\": \"Tamoxifen-inducible Cre knockout, histology, proliferation assay, ex vivo testis culture, RNA sequencing\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with tissue-specific deletion, multiple cellular and ex vivo readouts\",\n      \"pmids\": [\"29042623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PP1:NIPP1 fusions (covalently linked holoenzyme) cause replication stress requiring both PP1 catalytic activity and FHA domain-mediated substrate recruitment. PP1-NIPP1 expression leads to accumulation of RNA-DNA hybrids (R-loops), enhanced chromatin compaction, diminished DNA double-strand break repair, and reduced expression of DNA damage signaling/repair proteins.\",\n      \"method\": \"Inducible stable cell lines with PP1-NIPP1 fusion proteins, R-loop detection, DSB assay, chromatin compaction assay, gene expression analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — engineered covalent holoenzyme fusion with domain-mutant controls, multiple orthogonal readouts\",\n      \"pmids\": [\"29898919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Testis-specific NIPP1 deletion causes hyperphosphorylation of EZH2 at CDK sites Thr345 and Thr487 (due to loss of PP1-mediated dephosphorylation), leading to proteolytic EZH2 degradation and reduction in H3K27me3. Alanine mutations at these CDK sites prolong EZH2 half-life in germ cells. PP1:NIPP1 holoenzyme stabilizes EZH2 through dephosphorylation.\",\n      \"method\": \"Conditional knockout, phospho-specific antibody, alanine mutagenesis of EZH2, protein half-life assay, ChIP for H3K27me3\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — phosphosite mutagenesis with functional rescue, in vivo knockout, H3K27me3 ChIP, mechanistic chain established\",\n      \"pmids\": [\"30305391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NIPP1 inhibits PP1γ-mediated dephosphorylation of histone H3-Thr11 (H3-pThr11) both in vivo and in vitro. Upon DNA damage, activated PKA phosphorylates NIPP1-Ser199 (adjacent to the PP1-binding RVxF motif), triggering dissociation of NIPP1 from PP1γ, thereby activating PP1γ and enabling H3-pThr11 dephosphorylation and transcriptional repression of E2F1 target genes. NIPP1 depletion reduces expression of E2F1 target genes.\",\n      \"method\": \"In vitro PP1 inhibition assay, co-immunoprecipitation, NIPP1 depletion, PKA inhibitor treatment, ChIP for H3-pThr11\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro dephosphorylation assay, in vivo co-IP with phosphosite, functional gene expression readout, single lab\",\n      \"pmids\": [\"33939241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In C. elegans, loss of sut-6/NIPP1 or a C-terminal truncation (W292X, removing the RNA-binding domain) suppresses tau toxicity, tau protein accumulation and neuronal loss. Epistasis studies show that sut-6 suppression of tauopathy is independent of other nuclear speckle-localized suppressors (sut-2, aly-1/aly-3, spop-1). Neuronal overexpression of the W292X mutant (but not wild-type SUT-6) reduces tau-mediated deficits, suggesting the RNA-binding domain is required for NIPP1/sut-6's role in tau toxicity.\",\n      \"method\": \"C. elegans genetic screen, CRISPR-generated alleles, behavioral assay, tau protein quantification, neurodegeneration scoring, epistasis analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR alleles, epistasis, domain-truncation functional rescue, model organism ortholog\",\n      \"pmids\": [\"37000013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DNA damage activates the PP1:NIPP1 holoenzyme through a Src-family kinase-mediated phosphorylation of NIPP1 at C-terminal Tyr335, causing partial dissociation of the NIPP1 C-terminus from the PP1 active site. The phospho-Y335 C-terminus then interacts with the NIPP1 N-terminus (circularization), enhancing substrate recruitment by the flanking FHA domain. Knock-in of phospho-mimetic Y335E NIPP1 causes hypo-phosphorylation of FHA ligands and accumulation of DNA double-strand breaks, confirming this activation mechanism contributes to DNA repair resolution.\",\n      \"method\": \"In vitro kinase assay (Src-family kinase), PP1 activity assay, co-immunoprecipitation, NIPP1 Y335E knock-in cells, DSB quantification\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution, phosphomimetic knock-in with functional DSB readout, molecular mechanism of circularization established\",\n      \"pmids\": [\"38303113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NIPP-1 (Flag-tagged) co-immunoprecipitates with all three PP1 catalytic subunit isoforms (PP1α, PP1γ1, PP1δ) with similar efficiency in mammalian cells, indicating NIPP-1 interacts with PP1C through a region conserved among all three isoforms.\",\n      \"method\": \"Overexpression of Flag-tagged NIPP-1, co-immunoprecipitation with isoform-specific antibodies\",\n      \"journal\": \"The Tohoku journal of experimental medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single co-IP method, single lab, no mutagenesis or in vitro validation\",\n      \"pmids\": [\"10896038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Conditional knockout of NIPP1 from neural precursor cells in mice leads to significantly enhanced phosphorylation of tau, altered AKT and PP1 activity, decreased MBP expression in cortex, deficits in myelinated axon percentage and compound action potential conduction, and premature lethality. These findings establish a role for NIPP1 in regulating tau phosphorylation and CNS myelination in neural development.\",\n      \"method\": \"Conditional knockout mouse model, phospho-specific tau antibody, MBP immunostaining, electrophysiology (CAP recording), axon myelination quantification\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with multiple molecular and physiological readouts, single lab\",\n      \"pmids\": [\"36198882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Embryonic deletion of NIPP1 in keratinocytes leads to cell cycle arrest and premature senescence, with increased expression of cell cycle inhibitors p21, p16/Ink4a, p19/Arf, accumulation of senescence-associated secretory phenotype factors, and elevated DNA damage markers (γH2AX, 53BP1) in primary keratinocytes and human NIPP1-depleted HaCaT keratinocytes.\",\n      \"method\": \"Conditional knockout, primary keratinocyte culture, immunofluorescence (senescence markers, DNA damage markers), gene expression analysis\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with multiple cellular readouts and confirmation in human keratinocyte line, single lab\",\n      \"pmids\": [\"38431220\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PPP1R8/NIPP1 is a multidomain nuclear regulatory subunit of protein phosphatase 1 (PP1) that, through its central RVXF-containing inhibitory domain and C-terminal PP1-binding/RNA-binding domain, potently inhibits PP1 catalytic activity while targeting the holoenzyme to RNA and phosphoprotein substrates; its N-terminal FHA domain recruits phosphorylated substrates including the splicing factors SAP155 and CDC5L, the kinase MELK, and EZH2, enabling NIPP1:PP1 to control spliceosome assembly, EZH2 phosphorylation/stability and Polycomb-mediated H3K27me3 gene silencing, DNA damage repair threshold (through R-loop accumulation and DSB repair suppression), and cell migration via Cdc42; PKA phosphorylation of NIPP1-Ser199 adjacent to the RVXF motif dissociates NIPP1 from PP1 and activates PP1 toward substrates including H3-pThr11, while DNA damage triggers Src-family kinase phosphorylation of NIPP1-Tyr335, causing allosteric PP1:NIPP1 activation through NIPP1 circularization; loss of NIPP1 in vivo causes early embryonic lethality (gastrulation stage) due to impaired cell proliferation, as well as tissue-specific defects in spermatogenesis, liver progenitor suppression, neural myelination, and keratinocyte homeostasis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PPP1R8/NIPP1 is a nuclear regulatory subunit of protein phosphatase 1 (PP1) that builds substrate-selective PP1 holoenzymes controlling pre-mRNA splicing, Polycomb-mediated gene silencing, the DNA-damage response, and cell proliferation [#0, #5, #15, #25]. Through a centrally located inhibitory/PP1-binding domain (residues 143-217, with an RVxF motif at 200-203 and a ΦΦ-motif helix) it is among the most potent known PP1 inhibitors (Ki in the picomolar range) and engages PP1 at a unique, largely polar interaction surface that reshapes the holoenzyme's electrostatics and substrate selectivity [#0, #4, #19]. A second C-terminal PP1-binding element overlaps an RNA-binding domain (residues 330-351) that preferentially binds U-rich RNA and targets PP1 to RNA; PP1 inhibition requires the central and C-terminal sites cooperatively [#3, #6, #7]. The N-terminal FHA domain recognizes phosphorylated partners — the splicing factors SAP155/SF3b155 and CDC5L, the kinase MELK, and EZH2 — directing nuclear-speckle and spliceosomal targeting and substrate recruitment for the PP1:NIPP1 holoenzyme [#8, #9, #11, #12]. Functionally, NIPP1:PP1 controls late spliceosome assembly (the B-to-C complex transition) by promoting SAP155 dephosphorylation, then sensing its own substrate state and dissociating [#10, #17]. In parallel, NIPP1 recruits PP1 to chromatin in complex with PRC2 components EED and EZH2 (and HDAC2), where FHA docking onto CDK-phosphorylated EZH2 (Thr416) shields EZH2 from PP1 dephosphorylation, stabilizing EZH2 and sustaining H3K27me3 at proliferation-associated Polycomb targets [#13, #15, #18, #20, #26]. NIPP1 also gates the DNA-damage response: covalent PP1-NIPP1 holoenzymes drive R-loop accumulation, chromatin compaction, and suppressed double-strand-break repair, and the holoenzyme is switched on by post-translational signals — PKA phosphorylation of Ser199 next to the RVxF motif and Src-family-kinase phosphorylation of Tyr335 (driving C-terminal release and N-/C-terminal circularization) both activate PP1 toward FHA-recruited and histone substrates [#25, #27, #29]. Genetic loss is embryonic lethal at gastrulation from impaired proliferation, with conditional deletion producing tissue-specific defects in spermatogenesis, CNS myelination, and keratinocyte homeostasis [#14, #24, #31, #32].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established NIPP1 as a discrete, potent nuclear inhibitor of PP1 and localized its inhibitory activity to a defined central segment, answering what kind of regulator it is.\",\n      \"evidence\": \"cDNA cloning from bovine thymus with recombinant-fragment PP1 inhibition and phosphorylation assays\",\n      \"pmids\": [\"7499293\", \"8390458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the structural basis of PP1 binding\", \"Cellular substrates of the holoenzyme unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Mapped the kinase sites (PKA Ser178/Ser199, CK2 Thr161/Ser204) and showed phosphorylation regulates inhibitory potency, but within the holoenzyme activates PP1 without releasing NIPP1 — clarifying how the inhibitor is tuned.\",\n      \"evidence\": \"Baculovirus-expressed protein, tryptic phosphopeptide sequencing, quantitative PP1 inhibition assays\",\n      \"pmids\": [\"9407077\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of each phosphosite not established\", \"Substrate consequences not measured\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Revealed an unexpected RNA-binding activity in the C-terminus that targets PP1 to RNA, expanding NIPP1 from a simple inhibitor to a substrate-targeting subunit.\",\n      \"evidence\": \"North-Western, UV cross-linking, RNA mobility shift, poly(U)-Sepharose chromatography\",\n      \"pmids\": [\"9268347\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological RNA targets not identified\", \"Functional consequence of RNA-targeting of PP1 untested at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Dissected the modular architecture — a central inhibitory/RVxF site and a separate C-terminal PP1-binding/RNA-binding/cryptic endoribonuclease region — defining how distinct domains cooperate, and placed NIPP1:PP1 in nuclear speckles controlling pre-mRNA splicing.\",\n      \"evidence\": \"Yeast two-hybrid, far-Western, peptide competition, deletion fragments, immunodepletion with in vitro splicing assay\",\n      \"pmids\": [\"10318819\", \"11104670\", \"10432294\", \"9858469\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct splicing substrates of PP1:NIPP1 not yet identified\", \"Physiological role of the latent endoribonuclease activity unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified the FHA domain as a phospho-dependent recruiter (CDC5L) and defined separable nuclear-import (central NLS) versus speckle-targeting (FHA) signals, explaining how NIPP1 is positioned and how it selects substrates.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP/co-purification, EGFP-fusion live-cell microscopy, deletion mutagenesis\",\n      \"pmids\": [\"10827081\", \"11034904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of FHA ligands not yet enumerated\", \"Whether FHA recruitment couples to PP1 catalysis unresolved here\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed NIPP1 is a bona fide spliceosomal component acting at the B-to-C transition via its FHA domain, and identified SAP155 and MELK as additional phospho-dependent FHA ligands linking splicing control to cell-cycle kinases.\",\n      \"evidence\": \"In vitro spliceosome assembly assays, co-IP, kinase-inhibitor and phosphosite-mutant analyses\",\n      \"pmids\": [\"11909864\", \"12105215\", \"14699119\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct dephosphorylation of spliceosomal substrates not yet demonstrated\", \"Mechanism connecting MELK binding to splicing inhibition incompletely defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connected NIPP1 to Polycomb silencing by identifying EED interaction and transcriptional repressor activity, opening a chromatin role distinct from splicing.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, transcription reporter assays, domain mutagenesis\",\n      \"pmids\": [\"12788942\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Requirement for PP1 catalysis in repression not established here\", \"Genome-wide target spectrum unknown at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated NIPP1 is essential for cell proliferation and early development, establishing its physiological indispensability.\",\n      \"evidence\": \"Constitutive knockout mice, blastocyst outgrowth, RNAi, proliferation assays\",\n      \"pmids\": [\"15199142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular cause of the proliferation defect not pinpointed\", \"No viable null cell line, limiting mechanistic dissection\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided the mechanistic logic of FHA-directed substrate dephosphorylation: NIPP1 senses hyperphosphorylated SAP155, recruits PP1, drives dephosphorylation, then releases — defining it as a substrate-cycling sensor.\",\n      \"evidence\": \"In vitro dephosphorylation reconstitution, co-IP, siRNA, truncation-mutant splicing assays\",\n      \"pmids\": [\"18842582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of the sense-and-release cycle to other FHA ligands untested here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolved the structural basis of PP1 binding (intrinsically disordered domain forming a helix at a polar ΦΦ-motif site) and unified the chromatin model: FHA docking on CDK-phosphorylated EZH2 shields EZH2 from PP1, stabilizing it and retargeting Polycomb silencing of proliferation genes; also linked PP1:NIPP1 to Cdc42-dependent directional migration.\",\n      \"evidence\": \"NMR/crystallography with mutagenesis; co-IP, phospho-antibody, ChIP/DamID/ChIP-seq, electrotaxis with Cdc42 assays\",\n      \"pmids\": [\"22940584\", \"23241245\", \"20671031\", \"22815811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How holoenzyme assembly is choreographed in vivo across substrates not fully integrated\", \"Migration mechanism (PP1:NIPP1 substrates upstream of Cdc42) undefined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended the EZH2-stabilization model in vivo: testis-specific deletion causes germ-cell loss, and CDK-site EZH2 hyperphosphorylation leads to its degradation and loss of H3K27me3, establishing PP1:NIPP1 as an EZH2 stabilizer in a physiological setting.\",\n      \"evidence\": \"Conditional knockout, EZH2 phosphosite alanine mutants, protein half-life, H3K27me3 ChIP, ex vivo testis culture\",\n      \"pmids\": [\"29042623\", \"30305391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific differences in the proliferation requirement not explained\", \"Other dephosphorylation substrates contributing to germ-cell loss not excluded\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined a DNA-damage/genome-stability function: an engineered hyperactive PP1-NIPP1 holoenzyme drives R-loop accumulation, chromatin compaction, and suppressed DSB repair, requiring both catalysis and FHA recruitment.\",\n      \"evidence\": \"Inducible PP1-NIPP1 fusion cell lines, R-loop and DSB assays, chromatin compaction and gene-expression readouts\",\n      \"pmids\": [\"29898919\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct repair-pathway substrates dephosphorylated by the holoenzyme not identified\", \"Whether endogenous (non-fused) NIPP1 acts the same way needed validation\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified the activating switches of the holoenzyme: PKA phosphorylation of Ser199 dissociates NIPP1 to activate PP1γ toward H3-pThr11, and DNA-damage-triggered Src-family phosphorylation of Tyr335 releases the C-terminus and drives N-/C-terminal circularization to boost FHA-mediated substrate recruitment.\",\n      \"evidence\": \"In vitro PP1 activity/kinase assays, co-IP with phosphosites, Y335E knock-in cells, DSB quantification, ChIP\",\n      \"pmids\": [\"33939241\", \"38303113\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo kinase responsible for each event under physiological DNA damage not fully defined\", \"How circularization and dissociation are coordinated across substrate classes unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Implicated the NIPP1 RNA-binding domain in proteotoxicity: loss or C-terminal truncation of the ortholog suppresses tau toxicity, and conditional CNS deletion alters tau phosphorylation and impairs myelination/conduction, linking NIPP1 to neuronal homeostasis.\",\n      \"evidence\": \"C. elegans CRISPR alleles, epistasis, behavioral/neurodegeneration scoring; mouse neural conditional knockout with phospho-tau, MBP, and electrophysiology\",\n      \"pmids\": [\"37000013\", \"36198882\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular substrate connecting NIPP1 to tau phosphorylation unidentified\", \"Cross-species relevance of the RNA-binding-domain requirement uncertain\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated cell-type-specific proliferation control in vivo: keratinocyte deletion triggers cell-cycle arrest, senescence, and DNA damage marker accumulation, linking NIPP1 loss to genome-stress phenotypes.\",\n      \"evidence\": \"Conditional knockout, primary and HaCaT keratinocytes, senescence/DNA-damage immunofluorescence, gene expression\",\n      \"pmids\": [\"38431220\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal pathway from NIPP1 loss to senescence not mechanistically resolved\", \"Relationship to the EZH2/Polycomb and R-loop functions not directly tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the distinct activating signals (PKA-Ser199, SFK-Tyr335) and substrate-recruitment events are integrated to choose between splicing, Polycomb, and DNA-repair outputs in a given cell context remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified in vivo map of which substrates dominate per tissue\", \"Direct repair and migration substrates of PP1:NIPP1 unidentified\", \"Physiological role of the latent C-terminal endoribonuclease activity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 4, 17, 26]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2, 4, 6]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3, 6, 7]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 11, 17]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [5, 9]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [18, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [5, 10, 17]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [15, 18, 20, 26]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [25, 29]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [13, 16, 27]}\n    ],\n    \"complexes\": [\n      \"PP1:NIPP1 holoenzyme\",\n      \"spliceosome\",\n      \"PRC2 (NIPP1·EED·EZH2)\"\n    ],\n    \"partners\": [\n      \"PPP1CA\",\n      \"PPP1CC\",\n      \"SF3B1\",\n      \"CDC5L\",\n      \"MELK\",\n      \"EZH2\",\n      \"EED\",\n      \"HDAC2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}